NanoSyrinx
Coventry
About NanoSyrinx
NanoSyrinx is an emerging biotechnology company developing a novel system for targeted delivery of therapeutic proteins and peptides direct to the cytosol. We are using synthetic biology approaches to develop a completely novel method for targeted drug delivery of therapeutic proteins and peptides, to the interiors of cells, to improve efficacy, safety, and economy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $21.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2024)
- Website: nanosyrinx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nanosyrinx-5466 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.